100
Participants
Start Date
October 10, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Carfilzomib
Administered by intravenous infusion over 60 minutes.
Belatacept
Administered by intravenous infusion over 30 minutes.
NOT_YET_RECRUITING
NYU Langone Health, New York
RECRUITING
Duke University, Durham
NOT_YET_RECRUITING
University of Alabama Medical Center, Birmingham
NOT_YET_RECRUITING
Cleveland Clinic, Cleveland
NOT_YET_RECRUITING
University of Cincinnati, Cincinnati
NOT_YET_RECRUITING
University of Wisconsin - Madison, Madison
NOT_YET_RECRUITING
Northwestern University, Feinberg School of Medicine, Chicago
RECRUITING
Washington University, St Louis
RECRUITING
Mayo Clinic Arizona, Phoenix
NOT_YET_RECRUITING
UCLA, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID)
NIH